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Objectives: We undertook descriptive epidemiology of spot urine sodium-to-potassium ratio 
(Na/K) in a population sample to clarify the close relationship between Na/K and blood 
pressure level independently of potential confounding factors.  
Methods: Study participants consisted of 9,144 apparently healthy citizens (aged 54±13 
years). All clinical parameters were obtained at baseline.  
Results: Na/K was significantly higher in hypertensive subjects irrespective of 
antihypertensive medication status (normotension, 3.12±1.82; untreated hypertension 
3.50±1.96; treated hypertension, 3.72±2.53). As urinary Na (β=0.092, P<0.001) and K 
(β=−0.050, P<0.001) levels were inversely associated with blood pressure (BP), Na/K 
(β=0.118, P<0.001) was more closely associated with BP than Na or K alone, as well as daily 
salt intake estimated from urinary Na (β=0.088, P<0.001). Several factors were significantly 
associated with Na/K, namely age, sex, obesity, blood pressure, renal function, salt restriction 
status, serum phosphate and urinary creatinine level, and fasting period and season at urine 
sample collection. However, the association between Na/K and BP was independent of these 
factors (adjusted β=0.112, P<0.001). No direct association was observed between Na/K and 
large arterial remodeling assessed by pulse wave analysis (P=0.496) or retinal arteriolar 
morphological change (P=0.431). Further, a genome-wide association study failed to identify 
any particular genotype influencing urinary Na and K levels.  
Conclusions: Although we clarified several factors that might affect spot urine Na/K, these 
relationships were not substantial enough to confound the association between urinary Na/K 
and BP. A simple measure of Na/K might be more representative of salt loading obtained from 
spot urine samples than Na excretion alone. 
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INTRODUCTION 
Excessive salt intake is a risk factor for hypertension [1] and might directly increase risk of 
stroke [2, 3], while direct association with coronary heart disease remains inconclusive [3]. 
Conversely, a modest reduction in salt intake decreases blood pressure (BP) levels in both 
hypertensive patients and normotensives individuals [4], and the degree of BP decline 
(approximately 6 mmHg systolic BP [SBP] per 100 mmol reduction in 24-h urinary sodium) 
[4] substantially influences reduction in risk of cardiovascular disease [5]. Accurate 
assessment of daily salt load is therefore important when evaluating the risk of hypertension 
and cerebrovascular disease at both the individual and whole population levels. 
 The most reliable method for estimating daily salt intake in both clinical and 
epidemiological settings is measurement of 24-h urinary sodium excretion. A number of 
studies have confirmed an association between elevated salt intake as assessed by the 24-h 
urine method and increased BP levels [6]. However, 24-h urine collection is inconvenient for 
participants and cannot be easily adapted for large-scale cohort studies. Another simple 
method of estimating daily salt intake is an equation developed by Kawasaki et al. [7], which 
estimates 24-h urinary sodium (Na) and potassium (K) excretion based on second morning 
voiding urine. Tanaka et al. [8] developed another equation, which can also estimate 24-h 
urinary Na and K excretion from a spot urine sample. Although these equations are easy to 
use and have been adopted in several epidemiological studies [9], the accuracy of estimation 
is limited due to the large dispersion between the actual and estimated 24-h Na and K 
excretion levels [7, 8].  
 Sodium-to-potassium ratio (Na/K) of a urine sample is another index of salt loading. 
Given that potassium excretion level is inversely associated with BP [9] and potassium 
supplementation decreases BP levels [10, 11], the combined effect of lower potassium and 
higher sodium levels (i.e. higher Na/K) on BP appears to be greater than either alone [11, 12]. 
The superiority of Na/K was also observed in association with target organ damage, namely 
left ventricular hypertrophy [13] and cardiovascular disease (CVD) [14]. However, these 
studies used 24-h urine samples, and availability of Na/K data for spot urine samples is 
limited, despite a strong correlation being observed between spot urine Na/K and BP levels 
[15]. Recently, Iwahori et al. [16] reported that mean value of repeated measurement of spot 
urine Na/K was closely correlated to 24-h urine sample Na/K. These previous data emphasize 
the importance of elucidating the association of spot urine Na/K with BP levels and target 
organ damage, as well as clinical and environmental factors that might affect Na/K.  
 Here, we conducted a cross-sectional study by analyzing a dataset of the Nagahama 
Prospective Cohort for Comprehensive Human Bioscience (the Nagahama Study), which is a 
large-scale population-based cohort study in Japan, to further clarify factors that affects spot 
urine Na/K level, as well as the significance of spot urine Na/K with respect to BP level. We 
also conducted a genome-wide association study (GWAS) to identify any particular genotype 





Subjects consisted of 9,144 apparently healthy middle-aged to elderly citizens who 
participated in the Nagahama Prospective Cohort for Comprehensive Human Bioscience (the 
Nagahama Study). This cohort was recruited from 2008 to 2010 from the general population 
of Nagahama City, a largely rural city of 125,000 inhabitants located in central Japan. 
Community residents aged 30 to 74 years, living independently in the community and with no 
physical impairment or dysfunction, were recruited for the Nagahama cohort. Of 9,804 
potential participants, those meeting any of the following conditions were excluded: women 
whose urinary Na and K levels were not measured due to menstruation (n=447) or pregnancy 
(n=41), individuals with unsuccessful measurement of clinical parameters required for this 
study (n=79), individuals undergoing cancer therapy (n=58) or insulin therapy (n=24), or 
individuals with extreme deviation of renal function (estimated glomerular filtration rate 
[eGFR] = 194 × creatinine-1.094 × age-0.287 × 0.739 [if female], <30 mL/min/1.73 m2) (n=11). 
All study procedures were approved by the ethics committee of Kyoto University Graduate 
School of Medicine and by the Nagahama Municipal Review Board. Written informed 
consent was obtained from all participants. 
 
Spot urine sample 
Spot urine samples were collected at baseline measurements (09:00-17:00), and urinary Na, K, 
and creatinine (Cre) levels were measured on the day of sampling. Time since last meal was 
inquired about for each subject.  
 
Clinical parameters 
Basic clinical parameters, including plasma markers, were measured at baseline. Smoking 
habit, alcohol consumption, and salt restriction status were assessed using a structured 
self-administered questionnaire. Daily salt intake was estimated from urinary Na and Cre 
values using the following formula [8]: 
Daily salt intake = 21.98 × {Na (mEq/l) × predicted 24 h Cre excretion / [Cre (mg/dl) 
× 10]}0.392 × 0.0585 
where 24 h Cre excretion was predicted using the following formula:  
24 h Cre excretion = body weight (kg) × 14.89 + body height (cm) × 16.14 − age × 2.04 
− 2444.45.  
Brachial and central BP was measured simultaneously after 5 min rest in the sitting 
position. Measurements were taken twice, and the mean value was used in analysis. 
Brachial-to-ankle pulse wave velocity (baPWV) was measured as an index of large arterial 
stiffness, while central retinal arteriolar equivalent (CRAE) measured from a fundus 
photograph was used as an index of small arteriole change. Methods used for BP, baPWV, and 
CRAE measurement are detailed in the Supplementary Methods. 
 
Genetic analysis 
DNA was extracted from peripheral blood samples by a conventional phenol-chloroform 
method. Genome-wide single nucleotide polymorphism (SNP) analysis was performed with a 
subset of the Nagahama cohort sample (n=3,095) using a series of BeadChip DNA arrays 
(Illumina, San Diego, CA, USA). Replication analysis was performed with the remaining 
Nagahama samples with DNA available for genotyping, and the genotype of the candidate 
SNP was successfully analyzed (n=5,716). Genotypes were analyzed with a TaqMan probe 
assay using commercially available primer and probe sets purchased from Life Technologies 
Corporation (Carlsbad, CA, USA). Detailed methods of genotyping and association analysis 
are described in the Supplementary Methods.  
 
Statistical analysis 
Differences in numeric variables among subgroups were assessed by analysis of variance, 
while differences in frequency were assessed by a chi-squared test. Factors independently 
associated with Na/K, BP, baPWV, and CRAE were identified by multiple logistic regression 
analysis. All statistical analyses were performed using JMP 9.0.2 software (SAS Institute, 




Clinical characteristics of study subjects are shown in Table 1. Distribution of spot urine Na 
and K levels are shown in Supplementary Figure 1 and their scatter plots in Supplementary 
Figure 2. Although Na/K showed wide distribution (Supplementary Figure 3), 99.5% of 
subjects had ratios between 0.06 and 11.8. Spot urine Na/K was inversely associated with 
urinary Cre level (Supplementary Figure 4) due to the differences between urinary Na and K 
levels in relation to Cre levels (Supplementary Figure 5). Mean estimated daily salt intake 
was 9.8±2.1 g, and distribution of salt intake is shown in Supplementary Figure 6.  
 
Factors associated with spot urine Na/K 
Associations of clinical and lifestyle factors with spot urine Na/K are summarized in Table 2. 
Male sex, obesity, and current smoking, but not drinking habit, were positively associated 
with Na/K after adjustment for basic covariates. Further, subjects with careful salt intake had 
substantially lower Na/K. Older subjects had somewhat lower Na/K, but no clear 
age-dependency was observed (Supplementary Figure 7). No significant differences in Na/K 
were found between subjects with and without metabolic disorders, namely type 2 diabetes 
and dyslipidemia.  
 Fasting condition was strongly and inversely associated with spot urine Na/K (Figure 
1A), with substantially higher values during the non-fasting phase. Poorer renal function 
(Figure 1B) and higher serum phosphate (Figure 1C), but not calcium (Figure 1D), levels 
were also inversely associated with Na/K. Differences between Na and K in relation to 
environmental and clinical factors (Supplementary Figure 8) might explain the inverse 
association of Na/K with these factors.  
 Time at urine sample collection also influenced Na/K. However, while samples 
collected in the afternoon had significantly higher Na/K values than those collected in the 
morning (P<0.001) (Supplementary Figure 9), this difference nearly lost significance 
(P=0.031) after adjustment for covariates such as fasting time. Seasonal variations in spot 
urine Na/K were also noted, with lower values observed in the summer season. Mean monthly 
Na/K and temperature showed inverse relationships (Figure 2A).  
 Given the results of these correlation analyses, factors independently associated with 
urinary Na/K were identified by multivariate analysis (Supplementary Table 1). Factors 
showing a strong positive association with Na/K were body mass index (BMI) (β=0.051), 
SBP (β=0.126), eGFR (β=0.106), and antihypertensive medication status (β=0.048), while age 
(β=-0.104), salt restriction status (β=-0.057), serum phosphate levels (β=-0.152), urinary Cre 
levels (β=-0.312), season (β=−0.076) and fasting duration at urine sample collection 
(β=−0.177) showed an inverse association with urinary Na/K (P<0.001).  
 
Association of spot urinary Na/K with BP 
The association of spot urine Na/K with BP is shown in Figure 3. Na/K was significantly 
higher in hypertensive subjects, irrespective of antihypertensive medication status (Figure 3A), 
and linearly increased with BP (Figure 3B). Frequency analysis also revealed a linear positive 
association between urinary Na/K and prevalence of hypertension (Supplementary Figure 10).  
  Creatinine-adjusted urinary Na levels also increased linearly with BP, while urinary 
K levels showed an inverse association with BP (Supplementary Figures 11 and 12), even in a 
multivariate analysis adjusted for major covariates, namely age, sex, BMI, and 
antihypertensive medication status (Na/Cre: β=0.092, P<0.001, K/Cre: β=−0.050, P<0.001). 
Standardized coefficient of urinary Na/K to SBP (Table 3, Model 1) was therefore larger than 
that of Na or K alone, as was the coefficient of daily salt intake estimated from urinary Na 
(Model 2). When both Na/K and estimated daily salt intake were included in a same 
regression model, only Na/K was identified as a determinant for SBP (Na/K, β=0.105, 
P<0.001, variation inflation factor [VIF]=1.65; estimated daily salt intake, β=0.021, P=0.070, 
VIF=1.72). No substantial change was observed in the β of Na/K after full adjustment for 
covariates (Model 3) that were significantly associated with urinary Na/K. In contrast, no 
direct association was detected between urinary Na/K and large arterial remodeling as 
assessed by PWV (Model 4) or small arteriolar morphological changes as assessed by CRAE 
(Model 5). Although central BP has been suggested to be more closely associated with 
cardiovascular outcomes than brachial BP, association of urinary Na/K with central BP was 
not superior to that with brachial BP (Table 3, Model 6). 
 
GWAS of urinary Na and K levels 
We also conducted a GWAS to identify particular genotype influencing urinary Na and K 
levels (Supplementary Figures 13 to 16) using a subset of the Nagahama sample 
(Supplementary Table 4). Although P-values of several SNPs located in chromosome 1 
reached nearly genome-wide significance, a replication analysis using the remaining 




In this cross-sectional study of a large general population, we clarified that spot urine Na/K 
was more closely associated with BP than estimated daily salt intake calculated from urinary 
Na. Although many clinical and environmental factors substantially affected spot urine Na/K, 
these factors did not confound the association between urinary Na/K and BP.  
 
Epidemiological significance of spot urinary Na/K 
Several epidemiological studies for hypertension [9] used estimated daily salt intake 
calculated from spot urine Na level as an index of salt loading. However, as demonstrated in 
the present study, uncorrected Na/K exhibited a stronger correlation with BP than estimated 
salt intake. One reason for this improved association might be the limited accuracy of salt 
intake estimation; indeed, for both equations, when used in epidemiological studies [7, 8], the 
estimated daily salt intake showed wide dispersion compared to the actual value. Another 
reason might be the use of K as a factor in the calculation. Suggestions that urinary K is 
inversely associated with BP [9] may explain why Na/K rather than the salt intake estimated 
from Na excretion level exhibited a stronger correlation with BP. We also demonstrated the 
inverse association between urinary K and SBP in this study.  
 Spot urine Na/K was influenced by several clinical and environmental factors, 
namely fasting condition, sampling time and season, renal function, and anthropometric 
factors. Therefore, studies using spot urine Na/K should consider these confounding factors. 
Further investigations are required to clarify which urine sample is most appropriate for Na/K 
measurements, namely first morning urine, second morning voiding urine or other.  
 
Factors associated with spot urinary Na/K 
Several factors considerably influenced urinary Na/K, with urinary Cre exhibiting the 
strongest correlation. The reverse J-shape association between urinary Na and Cre, 
presumably representing lower urine volume in cases with elevated Cre levels, might have 
caused the inverse association between urinary Na/K and Cre. A second significant factor was 
fasting status with considerably lower urinary Na/K in the fasting phase. Large 
time-dependent declines in urinary Na levels versus K levels might be the cause of the 
fasting-time dependency of Na/K. The inverse association between Na/K and eGFR might 
also be due to the large decrease in urinary Na levels relative to renal functional decline. In 
contrast, serum phosphate concentration was positively associated with urinary K but not Na 
level. As a large proportion of urinary phosphate is reabsorbed at the proximal tubule by 
sodium-phosphate co-transporters [17], concomitant reabsorption of Na and consequently 
larger K efflux might be a plausible reason for this relationship between higher serum 
phosphate levels and greater K excretion. The lack of any association between serum calcium 
and urinary K level supports this consideration. These covariates were, however, unlikely to 
have any marked influence on the relationship between Na/K and BP. As shown in the results 
of our regression analysis for BP, the relatively small effect of these potential confounding 
factors on BP might be a reason for the independent association between Na/K and BP.  
 GWAS of urinary Na and K levels failed to identify any particular genotype 
influencing urinary Na and K levels. Environmental factors may strongly influence urinary 
Na and K excretion rather than the individual genetic variations. However, larger-scale 
GWAS might identify susceptible genotypes, as the sample size of our GWAS was limited 
compared to recent genetic association analyses of common diseases and clinical traits. 
 
Association of spot urine Na/K with BP and arterial properties 
Spot urine Na/K was linearly increased with BP level. Although Na/K of controlled 
hypertensive subjects were similar to those of healthy individuals, hypertensive subjects 
exhibited significantly higher Na/K irrespective of medication status. These results emphasize 
the importance of salt restriction not only for the prevention of hypertension but also in 
therapeutic intervention for hypertensive patients. 
 No direct association was observed between Na/K and large arterial stiffness 
assessed by baPWV. Although our study was based on a spot urine sample and might be a 
potential limitation in estimation of salt loading, the present results did not support the 
previously postulated direct adverse effects of excessive salt loading on target organ damage 
[2, 3]. Retinal vessels are the only visible arterioles and venules whose caliber can be easily 
measured by fundus photography, and retinal vessel signs such as the narrowing of CRAE 
have been associated with cardiovascular risk factors [18, 19], systemic inflammation [20], 
incidence of stroke [21, 22], and stroke death [23]. However, as shown in our previous report 
[24] and the present study, BP was the strongest determinant for CRAE, and urinary Na/K 
also did not appear to have direct adverse effects on small arterioles. Of note, to our 
knowledge, the present study is the first to investigate the association between urinary Na/K 
and morphological changes in retinal arterioles.  
 
Study limitations 
Several limitations to the present study warrant discussion. First, we used a spot urine sample, 
with no 24-h urine data available. Similarities and differences between spot urine Na/K and 
that of 24-h collected urine samples should be clarified. Second, as the present study was 
conducted in a cross-sectional setting, further longitudinal investigation is warranted to clarify 
the prognostic significance of spot urine Na/K on incidence of hypertension and 
cardiovascular diseases.  
 
Summary 
In conclusion, we clarified several covariates that might affect spot urine Na/K, though the 
association of Na/K with BP level was relatively unaffected by these clinical and 
environmental factors. A simple measure of spot urine Na/K might be more representative of 
salt loading obtainable from spot urine than estimated daily salt intake. Further longitudinal 
investigations are required to clarify the prognostic significance of spot urine Na/K. 
ACKNOWLEDGEMENTS 
We thank Dr. Yoshihiko Kotoura for his help regarding clinical measurements, Nagahama 
City Hall, and the non-profit Zeroji Club for their assistance in conducting this study. We also 
thank the editors of DMC Corporation for their help in the preparation of this manuscript. 
REFERENCES 
1. Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N 
Engl J Med. 2007;356:1966-1978. 
2. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular 
disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567. 
3. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of 
lower sodium intake on health: systematic review and meta-analyses. BMJ. 
2013;346:f1326. 
4. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood 
pressure: Cochrane systematic review and meta-analysis of randomized trials. BMJ. 
2013;346:f1325. 
5. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between 
local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation. 
1999;100:1387-1393. 
6. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications 
for public health. Int J Epidemiol. 2009;38:791-813. 
7. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary 
sodium and potassium excretion from second morning voiding urine specimen in adults. 
Clin Exp Pharmacol Physiol. 1993;20:7-14. 
8. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, Hashimoto T. A 
simple method to estimate populational 24-h urinary sodium and potassium excretion 
using a casual urine specimen. J Hum Hypertens. 2002;16:97-103. 
9. Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, 
et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl 
J Med. 2014;371:601-611. 
10. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of 
oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. 
JAMA. 1997;277:1624-1632. 
11. Morris RC Jr, Sebastian A, Forman A, Tanaka M, Schmidlin O. Normotensive salt 
sensitivity: effects of race and dietary potassium. Hypertension. 1999;33:18-23. 
12. Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N 
Engl J Med. 2007;356:1966-1978. 
13. Rodriguez CJ, Bibbins-Domingo K, Jin Z, Daviglus ML, Goff DC Jr, Jacobs DR Jr. 
Association of sodium and potassium intake with left ventricular mass: coronary artery 
risk development in young adults. Hypertension. 2011;58:410-416. 
14. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, 
et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: 
the Trials of Hypertension Prevention follow-up study. Arch Intern Med. 
2009;169:32-40. 
15. Hedayati SS, Minhajuddin AT, Ijaz A, Moe OW, Elsayed EF, Reilly RF, Huang CL. 
Association of urinary sodium/potassium ratio with blood pressure: sex and racial 
differences. Clin J Am Soc Nephrol. 2012;7:315-322. 
16. Iwahori T, Ueshima H, Miyagawa N, Ohgami N, Yamashita H, Ohkubo T, Murakami Y, 
et al. Six random specimens of daytime casual urine on different days are sufficient to 
estimate daily sodium/potassium ratio in comparison to 7-day 24-h urine collections. 
Hypertens Res. 2014;37:765-771. 
17. Murer H, Hernando N, Forster I, Biber J. Regulation of Na/Pi transporter in the proximal 
tubule. Annu Rev Physiol. 2003;65:531-542. 
18. Liew G, Sharrett AR, Wang JJ, Klein R, Klein BE, Mitchell P, Wong TY. Relative 
importance of systemic determinants of retinal arteriolar and venular caliber: the 
atherosclerosis risk in communities study. Arch Ophthalmol. 2008;126:1404-1410. 
19. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR, et al. Retinal 
vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of 
atherosclerosis (MESA). Invest Ophthalmol Vis Sci. 2006;47:2341-2350. 
20. de Jong FJ, Ikram MK, Witteman JC, Hofman A, de Jong PT, Breteler MM. Retinal 
vessel diameters and the role of inflammation in cerebrovascular disease. Ann Neurol. 
2007;61:491-495. 
21. Wong TY. Is retinal photography useful in the measurement of stroke risk? Lancet 
Neurol. 2004;3:179-183. 
22. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, et al. 
Prediction of incident stroke events based on retinal vessel caliber: a systematic review 
and individual-participant meta-analysis. Am J Epidemiol. 2009;170:1323-1332.  
23. Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, Klein BE, Wong TY, et al. 
Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older 
populations. Eur Heart J. 2007;28:1984-1992. 
24. Kumagai K, Tabara Y, Yamashiro K, Miyake M, Akagi-Kurashige Y, Oishi M, Yoshikawa 
M, et al. Central blood pressure relates more strongly to retinal arteriolar narrowing than 
brachial blood pressure: The Nagahama Study. J Hypertens. 2014 in press. 
 
FIGURE LEGENDS 
Figure 1. Factors associated with spot urine Na/K.  
Values are mean. Numbers of subjects in each subgroup are shown in columns. Estimated 
glomerular filtration rate (eGFR) was calculated using the following formula: 194 × Cre-1.094 
× age-0.287 × 0.739 [if female]. 
 
Figure 2. Seasonal variation in spot urine Na/K. 
A) Monthly mean urinary Na/K and temperature. Mean temperature during sampling period 
(2008 to 2010) was obtained from a database of the Japan Meteorological Agency. Months 
with mean temperature greater than 20 °C and less than 10 °C were regarded as summer and 
winter seasons, respectively. B) Seasonal mean urinary Na/K. Numbers of subjects in each 
subgroup are shown in columns.  
 
Figure 3. Association between BP and spot urine Na/K. 
Values are mean. A) Hypertension was defined as any or all of brachial SBP ≥140 mmHg, 
DBP ≥90 mmHg, or taking antihypertensive drugs. B) BP was graded according to the 
guideline for the management of hypertension by the Japanese Society of Hypertension; 
optimal, SBP <120 mmHg and DBP <80 mmHg; normal, SBP 120-129 mmHg and/or DBP 
80-84 mmHg; high normal, SBP 130-139 mmHg and/or DBP 85-89 mmHg; grade I 
hypertension, SBP 140-159 mmHg and/or DBP 90-99 mmHg; grade II hypertension, SBP 
160-179 mmHg and/or DBP 100-109 mmHg; grade III hypertension, SBP ≥180 mmHg and/or 
DBP ≥110 mmHg. 
 
Table 1. Clinical characteristics of study subjects (n=9,144) 
Age (years) 54±13 
Sex (male/female) 3,139/6,005 
BMI (kg/m2) 22.3±3.3 
Salt restriction (%) 51.9 
Blood pressure Brachial SBP (mmHg) 124±18 
 Central SBP (mmHg) 114±18 
 DBP (mmHg) 76±11 
 PP amplification (mmHg) 10±6 
 Antihypertensive medication (%) 17.6 
Glucose metabolism Glucose (mg/dl) 90±14 
 HbA1c (%) 5.5±0.5 
 Antihyperglycemic treatment (%) 2.7 
Plasma lipids Total cholesterol (mg/dl) 207±35 
 HDL cholesterol (mg/dl) 65±17 
 Triglyceride (mg/dl) 99±67 
 Antihyperlipidemic treatment (%) 12.4 
Electrolyte Phosphate (mg/dl) 3.51±0.46 
 Calcium (mg/dl) 9.05±0.35 
Renal function Serum Cre (mg/dl) 0.70±0.16 
 eGFR (ml/min/1.73m2) 79±16 
Urinary markers Cre (mg/dl) 90±65 
 Na (mEq/l) 128±62 
 Na/Cre 1.84±1.00 
 K (mEq/l) 49±31 
 K/Cre 0.62±0.26 
 Na/K 3.23±1.94 
Estimated daily salt intake (g) 9.8±2.1 
baPWV (cm/sec) 1271±226 
CRAE (µm) § 126±12 
BMI, body mass index; PP, pulse pressure; Cre, creatinine; baPWV, brachial-to-ankle pulse 
wave velocity; CRAE, central retinal arteriolar equivalent. 
Estimated glomerular filtration rate (eGFR) was calculated using the following formula: 194 
× Cre-1.094 × age-0.287 × 0.739 [if female]. Daily salt intake (g) was estimated from spot urine 
Na and Cre values using the following formula: 21.98 × {Na (mEq/l) × predicted 24 h Cre 
excretion / [Cre (mg/dl) × 10]}0.392 × 0.0585, where 24 h Cre excretion was predicted using 
the following formula: body weight (kg) × 14.89 + body height (cm) × 16.14 − age × 2.04 − 
2444.45 [8]. 
§Values available for 7,700 subjects. 
 
Table 2. Association of clinical and lifestyle factors with spot urine Na/K 





Sex Male (3,139) 3.38±2.02 <0.001  
 Female (6,005) 3.15±1.88   
     
Obesity  Obese (219) 3.69±2.02 <0.001  
 Overweight (1,515) 3.37±2.93   
 Normal weight (7,410) 3.18±1.91   
     
Drinking Habitual (2,141) 3.55±2.18 <0.001 0.657 
 Occasional (936) 3.32±2.15  0.841 
 Never or ever (6,066) 3.13±1.79  Reference 
     
Smoking Current (1,338) 3.37±2.00 <0.001 <0.001 
 Past (1,882) 3.25±1.91  0.889 
 None (5,924) 3.17±1.91  Reference 
     
Salt restriction Yes (4,745) 3.11±1.82 <0.001 <0.001 
 No (4,399) 3.36±2.04   
     
Type 2 diabetes Diabetes (382) 3.36±2.10 0.170 0.911 
 Control (8,762) 3.22±1.93   
     
Dyslipidemia Dyslipidemia (4,264) 3.28±1.96 0.011 0.355 
 Control (4,880) 3.18±1.92   
Values are mean ± standard deviation. Numbers of subjects in each subgroup are shown in 
parentheses.  
Obesity was defined as follows: obese, body mass index ≥30 kg/m2; overweight, ≥25 kg/m2; 
normal weight, <25 kg/m2.  
Type 2 diabetes was defined as any or all of HbA1c ≥6.5%, fasting plasma glucose ≥126 
mg/dl, occasional plasma glucose ≥200 mg/dl, or taking antihyperglycemic drugs. 
Dyslipidemia was defined as any or all of LDL cholesterol ≥140 mg/dl, HDL cholesterol <40 
mg/dl, triglyceride ≥150 mg/dl, or taking antihyperlipidemic drugs. Group differences were 
assessed by analysis of variance. Adjusted factors in the multivariate analysis were age, sex, 
body mass index, SBP, and antihypertensive medication. 
Table 3. Multivariate analysis for BP and arterial parameters 
 Dependent variables 
 Brachial SBP  baPWV  CRAE  Central SBP 
 Model 1§ Model 2§ Model 3#  Model 4¶  Model 5¶  Model 6§ 









Estimated daily salt intake (g)  0.088 (P<0.001)        
baPWV, brachial-to-ankle pulse wave velocity; CRAE, central retinal arteriolar equivalent (values are available for 7,700 subjects); Cre, urinary 
creatinine. 
Values are standardized regression coefficient and P-value. 
Daily salt intake (g) was estimated from spot urine Na and Cre values using the following formula: 21.98 × {Na (mEq/l) × predicted 24 h Cre 
excretion / [Cre (mg/dl) × 10]}0.392 × 0.0585, where 24 h Cre excretion was predicted using the following formula: body weight (kg) × 14.89 + 
body height (cm) × 16.14 − age × 2.04 − 2444.45 [8]. 
#Fully adjusted model including age, sex, BMI, salt restriction, current smoking habit, serum phosphate and urinary creatinine levels, seasonal 
variation, antihypertensive medication status, eGFR, and fasting duration at urine sampling as covariates. Full results of the regression analyses 
are shown in Supplementary Table 2. 
¶Adjusted for age, sex, BMI, current smoking habit, SBP, antihypertensive medication status, type 2 diabetes, and dyslipidemia. Full results of 
the regression analysis are shown in Supplementary Table 3.  
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Blood pressure (BP) measurements 
Radial arterial waveform and brachial BP were simultaneously measured (HEM-9000AI; 
Omron Healthcare, Kyoto, Japan) after 5 min rest in the sitting position. Briefly, brachial BP 
was measured at the right upper arm using a cuff-oscillometric device, and the radial arterial 
waveform was obtained from the left wrist using a multi-element tonometric sensor. The 
augmentation index (AIx) was calculated from the radial arterial waveform as the ratio of the 
late systolic peak to the first systolic peak. When AIx was less than 100%, absolute pressure 
of the late systolic peak (SBP2) of the radial arterial waveform, which was obtained by 
calibrating the first systolic peak with brachial SBP, was considered the central SBP. When 
AIx was more than 100%, brachial SBP was considered equal to central SBP. Central BP 
(SBP2) measured using the HEM-9000AI was therefore always lower than or equal to 
brachial SBP. Pulse pressure (PP) amplification was calculated by subtracting central PP from 
brachial PP and expressed in absolute values (mmHg). The validity of SBP2 in estimating 
central SBP has been demonstrated by invasive simultaneous measurement of the ascending 
aorta and radial artery pressure [1, 2]. Measurements were taken twice, and the mean value 
















Aortic pressure waveform Radial pressure waveform
Radial Augmentation index (%) 
= (PP2 / PP1) x 100 
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Measurement of brachial-to-ankle pulse wave velocity (PWV) 
Cuffs were applied to both brachia and ankles, and all BPs were simultaneously measured 
using a cuff-oscillometric device (Vasera-1500, Fukuda Denshi, Tokyo, Japan). The pulse 
volume waveforms were also recorded simultaneously using a plethysmographic sensor 
connected to the cuffs. The baPWV was calculated from the time interval between the wave 
fronts of the brachial and ankle waveforms, and the path length from the brachia to ankle 
(0.597 × height + 14.4014) [3, 4].  
 
Retinal vessel caliber measurements 
A fundus photograph of the right eye was used for retinal caliber measurements. 
Measurements were taken in each of the 6 largest arterioles and venules within a 0.5- to 1-disc 
diameter from the optic disc margin. Central retinal arteriolar equivalent (CRAE) were 
calculated using the formulas first developed by Hubbard et al. (1999) [5] and later modified 
by Kundtson (2003) [6], and then adjusted for ocular magnification by axial length, corneal 
curvature, and ocular refractive value using the Littmann method [7]. Corneal curvature and 
ocular refraction were measured using an automatic refractometer (Autorefractor ARK-530; 
Nidek, Tokyo, Japan). Axial lengths, from anterior pole to posterior pole of eyeball, were 
measured using a partial coherence interferometry device (IOLMaster; Carl Zeiss, Jena, 
Germany). Analysis was performed by three trained graders with no clinical information 
about the subject. 
 
Genome-wide association study (GWAS) 
Genome-wide single nucleotide polymorphism (SNP) analysis was performed with a subset 
of the Nagahama cohort sample using DNA extracted from peripheral blood samples by the 
phenol-chloroform method. Briefly, a series of BeadChip DNA arrays (Illumina, San Diego, 
CA, USA) were used for analysis, namely HumanHap610 quad (1,828 samples), 
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HumanOmni2.5-4 (1,616 samples), HumanOmni2.5-8 (378 samples), HumanOmni2.5s (192 
samples), HumanExome (192 samples), and HumanCoreExome (112 samples) (Illumina), and 
several samples were repeatedly genotyped using different arrays. Of a total of 3,712 
genotyped samples, 445 met the following criteria and were excluded from analysis: call rate 
of analyzed SNPs <95% (n=137), high degrees of kinship (Pi-hat >0.35, PLINK ver. 1.07 [8]) 
(n=301), and ancestry outliers as identified by principal component analysis with HapMap 
Phase 2 release 28 JPT dataset as reference (EIGENSTRAT ver.2.0 [9]) (n=7). Of the 3,267 
remaining samples, the available urinary sodium and potassium values (n=3,095) were used in 
the association analysis. 
 After applying a standard quality control for the genome-wide genotype data (call 
rate <99%, minor allele frequency <0.1%, or extreme deviation from Hardy-Weinberg 
equilibrium [p<1.0 × 10-6]), genotype imputation was performed by a standard two-step 
procedure using MACH ver. 1.0.16 software [9] with 1000 Genomes Phase I Integrated 
Release Version 3 for ASN (CHB+CHS+JPT) as a reference. As imputed SNPs with a minor 
allele frequency of <0.01 or R2 <0.3 were excluded, 7,280,945 SNPs were ultimately used in 
the association analysis. 
 Rank-based inverse normal transformation was applied to the urinary sodium (Na) 
and potassium (K) levels. GWAS of the normalized Na and K levels was performed by linear 
regression analysis under an additive genetic model adjusted for age, sex, and BMI. GWAS of 
urinary creatinine-adjusted Na and K levels was also performed by the same method. 
 
Replication genotype 
Replication analysis was performed with a subset of the remaining Nagahama samples for 
which clinical data and genomic data were available (n=5,732). Genotypes were analyzed 
with a TaqMan probe assay using commercially available primer and probe sets purchased 
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Supplementary Table 1. Multivariate analysis for spot urine Na/K 
 β P 
Age (years) -0.104 <0.001 
Sex (female) -0.035 0.002 
BMI (kg/m2) 0.051 <0.001 
Salt restriction status -0.057 <0.001 
Current smoking habit 0.027 0.009 
Seasonal variation# Middle 0.002 0.866 
 Summer -0.076 <0.001 
Brachial SBP (mmHg) 0.126 <0.001 
Antihypertensive medication status 0.048 <0.001 
Fasting time (h) -0.177 <0.001 
eGFR (ml/min/1.73 m2) 0.106 <0.001 
Serum phosphate (mg/dl) -0.152 <0.001 
Urinary creatinine (mg/dl) -0.312 <0.001 
BMI, body mass index; eGFR, estimated glomerular filtration rate  
eGFR was calculated using the following formula: 194 × creatinine-1.094 × age-0.287 × 0.739 (if 
female). 
#Calculated using winter season as a reference  
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Supplementary Table 2. Multivariate analysis for brachial SBP 
 β P 
Age (years) 0.344 <0.001 
Sex (female) -0.153 <0.001 
BMI (kg/m2) 0.170 <0.001 
Salt restriction status 0.024 0.009 
Current smoking habit 0.006 0.549 
Seasonal variation# Middle 0.006 0.566 
 Summer -0.046 <0.001 
Antihypertensive medication status 0.104 <0.001 
Fasting time (h) 0.031 0.001 
eGFR (ml/min/1.73 m2) -0.016 0.128 
Serum phosphate (mg/dl) -0.046 <0.001 
Urinary creatinine (mg/dl) -0.016 0.117 
Urinary Na/K 0.112 <0.001 
BMI, body mass index; eGFR, estimated glomerular filtration rate 
eGFR was calculated using the following formula: 194 × creatinine-1.094 × age-0.287 × 0.739 (if 
female). 
#Calculated using winter season as a reference 
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Supplementary Table 3. Multivariate analysis for arterial parameters 
 baPWV  CRAE 
 β  P  β P 
Age (years) 0.420 <0.001  -0.078 <0.001 
Sex (female) -0.008 0.259  -0.028 0.020 
BMI (kg/m2) -0.037 <0.001  0.007 0.562 
Current smoking habit -0.005 0.478  0.073 <0.001 
SBP (mmHg) 0.415 <0.001  -0.269 <0.001 
Antihypertensive 
medication status 
0.105 <0.001  -0.046 <0.001 
Type 2 diabetes 0.058 <0.001  0.018 0.107 
Hyperlipidemia 0.034 <0.001  0.016 0.162 
Urinary Na/K 0.005 0.496  -0.009 0.431 
baPWV, brachial-to-ankle pulse wave velocity; CRAE, central retinal arteriolar equivalent 
(values are available for 7,700 subjects); BMI, body mass index 
Type 2 diabetes was defined as any or all of HbA1c ≥6.5%, fasting plasma glucose ≥126 
mg/dl, occasional plasma glucose ≥200 mg/dl, or taking antihyperglycemic drugs. 
Dyslipidemia was defined as any or all of LDL cholesterol ≥140 mg/dl, HDL cholesterol <40 
mg/dl, triglyceride ≥150 mg/dl, or taking antihyperlipidemic drugs. 
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Age (years) 53±14 55±13 
Sex (male/female) 1,089/2,006 1,924/3,792 
BMI (kg/m2) 22.3±3.2 22.4±3.3 
Urinary markers Na (mEq/l) 127±62 128±63 
 Na/Cre 1.85±1.02 1.83±0.98 
 K (mEq/l) 49±31 49±31 
 K/Cre 0.63±0.27 0.62±0.26 
 Na/K 3.22±1.97 3.22±1.92 
BMI, body mass index; Cre, urinary creatinine; GWAS, genome-wide association study 
Values are mean ± standard deviation. 
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Supplementary Table 5. A top-hit SNP in GWAS of urinary sodium level 
Chr rs Number 






















GWAS, genome-wide association study; Chr, chromosome; HWE, Hardy-Weinberg equilibrium; s.e., standard error 
Urinary sodium value was transformed by rank-based inverse normal transformation. β and P-values in the additive regression models adjusted 







Supplementary Figure 1. Histograms of spot urine Na and K 











































































































Supplementary Figure 2. Scatter plot of spot urine Na and K. 


























Supplementary Figure 3. Histogram of spot urine Na/K 












































Supplementary Figure 4. Scatter plot of spot urine creatinine and Na/K 






























Supplementary Figure 5. Associations of spot urine creatinine with Na, K, and Na/K  



























































Supplementary Figure 6. Histogram of estimated daily salt intake 
Number of subjects in each subgroup is indicated above each bar. Daily salt intake (g) was 
estimated from spot urinary sodium and creatinine values using the following formula 
(Tanaka et al., J Hum Hypertens. 2002;16:97-103):  
   21.98 × {Na (mEq/l) × predicted 24 h Cre excretion / [Cre (mg/dl) × 10]}0.392 × 0.0585,  
where 24 h Cre excretion was predicted using the following formula:  
   body weight (kg) × 14.89 + body height (cm) × 16.14 − age × 2.04 − 2444.45. 
























































Supplementary Figure 7. Age related changes in spot urine Na/K 
Each column indicates mean value. Numbers of subjects in each subgroup are shown in 




















































Supplementary Figure 8. Association of environmental and clinical factors with spot urine Na and K levels 
Association of urinary Na and K with A) time since last meal, B) eGFR, C) serum phosphate, and D) serum calcium. Urinary Na and K levels 










































































Supplementary Figure 9. Association of urine sample collection time with Na/K 
Each column indicates mean value. Number of subjects in each subgroup is indicated in 
columns. Timestamp of pulse wave velocity measurement was used as a substitute for urine 
sample collection. Differences in mean values were assessed by analysis of variance. 
Covariate adjusted analysis was performed using a linear regression model with adjustment 
for the following factors: age, sex, body mass index, salt restriction, current smoking, 
seasonal variation, brachial SBP, antihypertensive medication, fasting time, estimated 







































































































Supplementary Figure 10. Differences in frequency of hypertension by spot urine Na/K 
Number of subjects in each subgroup is shown in the parentheses. Left panel: hypertension was defined as any or all of SBP ≥140 mmHg, DBP 
≥90 mmHg, or taking antihypertensive drugs. Right panel: grade of hypertension was defined according to the guideline for the management of 
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(n=9,144)








Supplementary Figure 11. Association of BP with creatinine-adjusted spot urine Na and K levels. 
Number of subjects in each subgroup is shown in the parentheses. Hypertension was defined as any or all of brachial SBP ≥140 mmHg, DBP ≥90 












































































































Supplementary Figure 12. Association of BP with creatinine-adjusted spot urine Na and K levels. 
Number of subjects in each subgroup is shown in the parentheses. BP was graded according to the guideline for the management of hypertension 
by the Japanese Society of Hypertension; optimal, SBP <120 mmHg and DBP <80 mmHg; normal, SBP 120-129 mmHg and/or DBP 80-84 
mmHg; high normal, SBP 130-139 mmHg and/or DBP 85-89 mmHg; grade I hypertension, SBP 140-159 mmHg and/or DBP 90-99 mmHg; 











































































































Supplementary Figure 13.  Manhattan plots of association analysis for spot urine Na and K 
levels 
Rank-based inverse normal transformation was applied to urinary Na and K values to 
normalize their distributions. Adjusted factors in the association analysis were age, sex, and 
body mass index. Association analysis was performed using PLINK v1.07 software. 
 





































Supplementary Figure 14.  Quantile-Quantile plots of the association analysis for spot urine 
Na and K 
The Quantile-Quantile plot (QQ-plot) for the P-values of all SNPs that passed quality control 
criteria and for the P-values corrected for genomic control factor are indicated by blue and red 
















































Supplementary Figure 15.  Regional association plots of loci around the SNP rs12092050 
A) P-values (-log10[p]) of genotyped SNPs around 200 kb to either side of the most strongly 
associated signal are shown in red dots. Genomic positions are based on NCBI reference 
sequence build 36 and dbSNP build 126. B) Red line indicates the recombination rate 
(cM/Mb) estimated from a HapMap JPT (release 28) dataset. Purple line indicates cumulative 
genetic distance (in cM) from the strongest signal. C) Blue lines (intron) and boxes (exon) 
indicate the locations of known genes (no gene in this region). D) Linkage disequilibrium 















Supplementary Figure 16.  Manhattan plots of association analysis for creatinine-adjusted 
spot urine Na and K levels 
Adjusted factors in the association analysis were age, sex, and body mass index. Association 
analysis was performed using PLINK v1.07 software. 
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